Companies › AbbVie

AbbVie

Company Pharma & Medical Devices

AbbVie is listed as a company in Pharma & Medical Devices. It has filed 10 comment letters on 10 proposed federal rules between 2025 and 2026, most often with the Centers for Medicare & Medicaid Services.

Type
Company
Industry
Pharma & Medical Devices
Comment letters
10
Rules commented on
10
First letter
2025-09-16
Latest letter
2026-09-08
Agencies most often
Centers for Medicare & Medicaid Services (6); Office of Inspector General (1); Health and Human Services Department (1)

Activity by year

20251
20269

Letters

2026

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

HHSIG-2026-0034Health and Human Services Department, Office of Inspector General · filed 2026-09-08 · filed as “AbbVie Inc.”

Medicare Drug Price Negotiation Program and Medicare Prescription Drug Benefit Program

CMS-2026-2080Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-02

Medicare Program: Hospital Outpatient Prospective Payment and Ambulatory Surgical Center Payment Systems; and Quality Reporting Programs; Including the Hospital Outpatient Quality Reporting Program and Ambulatory Surgical Center Quality Program; Request for Information on Strengthening the Standardization and Comparability of Hospital Price Transparency (HPT) Data; Prior Authorization; Accrediting Organization (AO) Deeming for Emergency Medical Treatment and Labor Act (EMTALA); and Notices of Closure of Teaching Hospitals and Opportunities To Apply for Available Slots

CMS-2026-2344Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-09-01

Request for Information (RFI): Pharmacy Benefit Manager Compensation and Data Collection

CMS-2026-2212Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-07-24 · filed as “AbbVie Inc”

Request for Information; Comprehensive Review of the Essential Health Benefits Framework and Typical Employer Plan Standard

CMS-2026-2081Health and Human Services Department · filed 2026-07-17 · filed as “AbbVie Inc”

Medicare and Medicaid Programs; Patient Protection and Affordable Care Act; Interoperability Standards and Prior Authorization for Drugs for Medicare Advantage Organizations, Medicaid Managed Care Plans, State Medicaid Agencies, Children's Health Insurance Program (CHIP) Agencies and CHIP Managed Care Entities, and Issuers of Qualified Health Plans on the Federally-Facilitated Exchanges

CMS-2026-1255Health and Human Services Department, Centers for Medicare & Medicaid Services, Office of the Secretary · filed 2026-06-29 · filed as “AbbVie Inc.”

Medicare and State Health Care Programs: Fraud and Abuse; Request for Information Regarding the Federal Anti-Kickback Statute and Beneficiary Inducements CMP

HHSIG-2026-0001Health and Human Services Department, Inspector General Office, Health and Human Services Department · filed 2026-04-02 · filed as “AbbVie Inc.”

Global Benchmark for Efficient Drug Pricing (GLOBE) Model

CMS-2025-1889Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

Guarding U.S. Medicare Against Rising Drug Costs (GUARD) Model

CMS-2025-1888Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2026-02-25

2025

Medicare and Medicaid Programs; CY 2026 Payment Policies Under the Physician Fee Schedule and Other Changes to Part B Payment and Coverage Policies; Medicare Shared Savings Program Requirements; and Medicare Prescription Drug Inflation Rebate Program; Correction

CMS-2025-0304Health and Human Services Department, Centers for Medicare & Medicaid Services · filed 2025-09-16